BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11774366)

  • 21. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6.
    Crespi CL; Penman BW; Gelboin HV; Gonzalez FJ
    Carcinogenesis; 1991 Jul; 12(7):1197-201. PubMed ID: 2070484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UVA activation of N-dialkylnitrosamines releasing nitric oxide, producing strand breaks as well as oxidative damages in DNA, and inducing mutations in the Ames test.
    Arimoto-Kobayashi S; Sano K; Machida M; Kaji K; Yakushi K
    Mutat Res; 2010 Sep; 691(1-2):47-54. PubMed ID: 20637784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of human cytochrome P450 1B1, 1A1 and 1A2 by antigenotoxic compounds, purpurin and alizarin.
    Takahashi E; Fujita K; Kamataki T; Arimoto-Kobayashi S; Okamoto K; Negishi T
    Mutat Res; 2002 Oct; 508(1-2):147-56. PubMed ID: 12379470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.
    Tiano HF; Wang RL; Hosokawa M; Crespi C; Tindall KR; Langenbach R
    Carcinogenesis; 1994 Dec; 15(12):2859-66. PubMed ID: 8001247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase.
    Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y
    Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli.
    Iwata H; Fujita K; Kushida H; Suzuki A; Konno Y; Nakamura K; Fujino A; Kamataki T
    Biochem Pharmacol; 1998 Apr; 55(8):1315-25. PubMed ID: 9719488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative metabolism of N-nitrosopiperidine and N-nitrosopyrrolidine by rat liver and esophageal microsomes and cytochrome P450 2A3.
    Wong HL; Murphy SE; Wang M; Hecht SS
    Carcinogenesis; 2003 Feb; 24(2):291-300. PubMed ID: 12584180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ethanol treatment on DNA damage induced in Escherichia coli K-12 in various organs of mice by N-nitro-sonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosopyrrolidine.
    Knasmüller S; Kassie F; Zöhrer E; Kundi M; McCoy DG; Schulte-Hermann R
    Carcinogenesis; 1994 Feb; 15(2):263-70. PubMed ID: 8313517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5.
    Emmert B; Bünger J; Keuch K; Müller M; Emmert S; Hallier E; Westphal GA
    Toxicology; 2006 Nov; 228(1):66-76. PubMed ID: 16978761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism-dependent mutagenicity of two structurally similar tobacco-specific nitrosamines (N-nitrosonornicotine and N-nitrosoanabasine) in human cells, partially different CYPs being activating enzymes.
    Chen Y; Yang Z; Zhou Z; Liu EJ; Luo W; He Z; Han W; Liu Y
    Toxicology; 2024 May; 504():153774. PubMed ID: 38490321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biotransformation of (-)-camphor by Salmonella typhimurium OY1002/2A6 expressing human CYP2A6 and NADPH-P450 reductase.
    Nakahashi H; Miyazawa M
    J Oleo Sci; 2011; 60(10):545-8. PubMed ID: 21937854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutagenic and cytogenetic studies of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Padma PR; Amonkar AJ; Bhide SV
    Cancer Lett; 1989 Aug; 46(3):173-80. PubMed ID: 2670197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Tiano HF; Hosokawa M; Chulada PC; Smith PB; Wang RL; Gonzalez FJ; Crespi CL; Langenbach R
    Carcinogenesis; 1993 Jul; 14(7):1421-7. PubMed ID: 8330360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic effects of the flavonoids quercetin and naringenin on the metabolic activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline by Salmonella typhimurium TA1538 co-expressing human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Kang IH; Kim HJ; Oh H; Park YI; Dong MS
    Mutat Res; 2004 Jan; 545(1-2):37-47. PubMed ID: 14698415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of mutagenicity during degradation of N-nitrosamines by advanced oxidation processes.
    Mestankova H; Schirmer K; Canonica S; von Gunten U
    Water Res; 2014 Dec; 66():399-410. PubMed ID: 25240607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial mutagenicity of some tobacco aromatic nitrogen bases and their mixtures.
    Yim SH; Hee SS
    Mutat Res; 2001 May; 492(1-2):13-27. PubMed ID: 11377240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
    Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
    Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the CYP isozyme profile induced by cyclohexanol.
    Espinosa-Aguirre JJ; Rubio J; López I; Nosti R; Asteinza J
    Mutagenesis; 1997 May; 12(3):159-62. PubMed ID: 9175641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
    Smith TJ; Guo Z; Guengerich FP; Yang CS
    Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.